Back
Goldman Sachs Acss Invmt Grd Corp Bd ETF Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
46
GIGB
Goldman Sachs Acss Invmt Grd Corp Bd ETF
Last Price:
45.76
Seasonality Move:
-1.48%
Sell
1
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
12.89%
Sell
46
Goldman Sachs Acss Invmt Grd Corp Bd ETF (GIGB)
is a Sell
Is Goldman Sachs Acss Invmt Grd Corp Bd ETF a Buy, Sell or Hold?
- The current Goldman Sachs Acss Invmt Grd Corp Bd ETF [GIGB] share price is $45.78. The Score for GIGB is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- GIGB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.97. The Score for AGIO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GIGB Stock Price Chart
What is Goldman Sachs Acss Invmt Grd Corp Bd ETF's stock price today?
-
The Goldman Sachs Acss Invmt Grd Corp Bd ETF share price today is $45.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GIGB is experiencing selling pressure, which indicates risk of future bearish movement.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GIGB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 40.51 | Sell |
Chaikin Money Flow: | -19138 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.71 - 46.29) | Sell |
Bollinger Bands (100): | (45.88 - 47.02) | Sell |
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.2 | Sell |
Relative Strength Index (14 RSI): | 28.25 | Sell |
Chaikin Money Flow: | 740295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.22 - 61.14) | Sell |
Bollinger Bands (100): | (41.85 - 53.15) | Sell |
GIGB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.21 | Sell |
20-day SMA: | 46.04 | Sell |
50-day SMA: | 46.12 | Sell |
200-day SMA: | 45.84 | Sell |
8-day EMA: | 46.1 | Sell |
20-day EMA: | 46.1 | Sell |
50-day EMA: | 46.17 | Sell |
200-day EMA: | 45.93 | Sell |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.4 | Sell |
20-day SMA: | 53.73 | Sell |
50-day SMA: | 49.6 | Sell |
200-day SMA: | 41.93 | Sell |
8-day EMA: | 46.69 | Sell |
20-day EMA: | 51.08 | Sell |
50-day EMA: | 50.45 | Sell |
200-day EMA: | 42.79 | Sell |
Goldman Sachs Acss Invmt Grd Corp Bd ETF Earnings Growth & GIGB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
Goldman Sachs Acss Invmt Grd Corp Bd ETF Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Agios Pharmaceuticals Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |